- Take Advantage of Glutamine Anaplerosis, the Kernel of the Metabolic Rewiring in Malignant Gliomas
Filipa Martins et al, 2020, Biomolecules CrossRef - Cancer Stem Cells: Significance in Origin, Pathogenesis and Treatment of Glioblastoma
Karina Biserova et al, 2021, Cells CrossRef - Contribution of the Wnt Pathway to Defining Biology of Glioblastoma
Marton Tompa et al, 2018, NeuroMolecular Medicine CrossRef - To be Wild or Mutant: Role of Isocitrate Dehydrogenase 1 (IDH1) and 2-Hydroxy Glutarate (2-HG) in Gliomagenesis and Treatment Outcome in Glioma
Bharathan Bhavya et al, 2020, Cellular and Molecular Neurobiology CrossRef - Tumor recurrence or treatment-related changes following chemoradiation in patients with glioblastoma: does pathology predict outcomes?
Anthony Patrizz et al, 2021, Journal of Neuro-Oncology CrossRef - Lentiviral Vectors as Tools for the Study and Treatment of Glioblastoma
Claudia Del Vecchio et al, 2019, Cancers CrossRef - IDH1R132H Causes Resistance to HDAC Inhibitors by Increasing NANOG in Glioblastoma Cells
Geon-Hee Kim et al, 2019, International Journal of Molecular Sciences CrossRef - In vivo C6 glioma models: an update and a guide toward a more effective preclinical evaluation of potential anti-glioblastoma drugs
Safura Pournajaf et al, 2024, Reviews in the Neurosciences CrossRef - Opposed Interplay between IDH1 Mutations and the WNT/β-Catenin Pathway: Added Information for Glioma Classification
Alexandre Vallée et al, 2021, Biomedicines CrossRef - Reprogramming the immunosuppressive microenvironment of IDH1 wild-type glioblastoma by blocking Wnt signaling between microglia and cancer cells
Dandan Fan et al, 2021, OncoImmunology CrossRef